RecruitingNCT00025935

Studies of Brain Function and Course of Illness in Pediatric Bipolar Disorder

Characterization and Pathophysiology of Severe Mood and Behavioral Dysregulation in Children and Youth


Sponsor

National Institute of Mental Health (NIMH)

Enrollment

2,350 participants

Start Date

Jan 1, 2002

Study Type

OBSERVATIONAL

Conditions

Summary

This study seeks to learn more about the symptoms of severe mood dysregulation in children and adolescents ages 7-17. Children and adolescents with severe mood dysregulation (SMD) display chronic anger, sadness, or irritability, as well as hyperarousal (such as insomnia, distractibility, hyperactivity) and extreme responses to frustration (such as frequent, severe temper tantrums). Researchers will describe the moods and behaviors of children with these symptoms and use specialized testing and brain imaging to learn about the brain changes associated with this disorder....


Eligibility

Min Age: 7 YearsMax Age: 60 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Lithium for people with mood disorder. The study is currently recruiting participants at 1 location. People eligible for this study include aged 7 Years to 60 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGLithium

Locations(1)

National Institutes of Health Clinical Center

Bethesda, Maryland, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT00025935


Related Trials